The World Market for Prescription Generic Drugs, 5th Edition

Table of Contents

Chapter One: Executive Summary

• Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Trends Affecting the Market
  • Market Outlook

Chapter Two: Introduction

• Industry Development
  • Generic Drug Industry Evolution
  • FDA Regulation
  • Development and Approval Process
• Industry Structure
• Product Distribution
• Patent Expirations

Chapter Three: Allergy and Respiratory Drugs

• Product Categories
  • Asthma, Bronchodilators and Corticosteroids
  • Inhaled Corticosteroids
  • Antiasthmatic Agents
  • Bronchodilating Agents
  • Antihistamines, Decongestants, and Cough Preparations
  • Antihistamines
  • Decongestants
  • Cough Preparations
• Product News
• Market Size and Forecast
  • The World Market
  • The U.S. vs World Market
• Competitive Analysis

Chapter Four: Analgesics, Nonsteroidal Anti-Inflammatory Drugs, and Antirheumatic Drugs

• Product Categories
  • Analgesics
  • Nonsteroidal Anti-inflammatory Drugs
  • Antirheumatics
• Product News
• Market Size and Forecast
  • The World Market
  • The U.S. vs World Market
• Competitive Analysis

Chapter five: Anesthesia Drugs

• Product Categories
  • General
  • Local
  • Regional
• Product News
• Market Size and Forecast
  • The World Market
  • The U.S. vs World Market
• Competitive Analysis

Chapter Six: Anti-Infectives

• Product Categories
  • Systemic Anti-Infectives
  • Topical Anti-Infectives
• Product News
• Market Size and Forecast
  • The World Market
  • The U.S. vs World Market
• Competitive Analysis

Chapter seven: Cancer Drugs

• Products
  • Product News
  • Market Size and Forecast
    • The World Market
    • The U.S. vs World Market
  • Competitive Analysis

Chapter Eight: Cardiovascular Drugs

• Product Categories
  • Positive Inotropic Agents
  • Antiadrenergics
  • Beta-Adrenergic Blocking Agents
  • Vasodilators
  • Calcium Channel Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antiarrhythmics
  • Antihyperlipidemic Agents
  • Anticoagulants
  • Diuretics
• Product News
• Market Size and Forecast
  • The World Market
  • The U.S. vs. World Market
• Competitive Analysis

Chapter Nine: Central Nervous System and Psychotherapeutic Drugs

• Product Categories
  • Antidepressants, Stimulants, and Antipsychotics
  • Antidepressants
  • Stimulants
  • Antipsychotics
  • Anticonvulsants, Antispasmodics, and Muscle Relaxants
  • Anticonvulsants
  • Antispasmodics
  • Muscle Relaxants
  • Parkinsons Disease, Myasthenia Gravis, and Multiple Sclerosis
  • Parkinsons Disease
  • Myasthenia Gravis
  • Multiple Sclerosis
  • Sedatives, Hypnotics, and Antianxiety Drugs
• Product News
• Market Size and Forecast
  • The World Market
  • The U.S. vs World Market
• Competitive Analysis

Chapter Ten: Gastrointestinal Drugs

• Product Categories
  • Antidiarrheals
  • Antinauseants
  • Antispasmodics
  • Antiulcer
  • Digestants
• Product News
  • Market Size and Forecast
  • The World Market
  • The U.S. vs the World Market
• Competitive Analysis

Chapter Eleven: Hormonal Drugs

• Product Categories
  • Male and Female Hormones
  • Corticosteroids
  • Diabetes Drugs
  • Thyroid Drugs
• Product News
• Market Size and Forecast
  • The World Market
  • U.S. vs World Market
• Competitive Analysis

Chapter Twelve: Ophthalmic Drugs

• Product Categories
  • Ophthalmic Anti-Infectives
  • Ophthalmic Anti-Inflammatories and Mast Cell Inhibitors
  • Glaucoma Agents
• Product News
  • Market Size and Forecast
  • The World Market
  • U.S. vs World Market
• Competitive Analysis

Chapter Thirteen: World Market Summary

• Overview
  • Total Market Size and Forecast
  • Market and Competitive Analysis

Chapter Fourteen: Issues and Trends

• Understanding Hatch-Waxman and Its Shortfalls
  • The FDA, Funding and Review Times
  • Big Pharma Tactics Defensive and Offensive
  • Authorized Generics
  • Generic Biologics
  • Medicaid Generic Drug Reimbursement Issues
  • The Elderly
  • Confusion in Generic Drug Names
  • Broadening Generic Horizons
  • International Generic Drug Issues
  • Industry Consolidation
  • New Generic Giants
  • Patent Issues: Filings and Challenges
  • Patent Reform
  • Generic Growth: Prescriptions, Approvals, Impact
  • Generic Statins Countdown
  • Prescription Drug Costs
  • Generics Improve Compliance
  • Generic Drug Sampling

Chapter Fifteen: Company Profiles

• Industry Structure and Participants
  • Actavis Group
  • Altana Pharma AG
  • Andrx Corporation
  • Apotex Group
  • Aurobindo Pharma, Ltd
  • Barr Laboratories, Inc.
  • Bedford Laboratories
  • Lannett Company, Inc.
  • Mylan Laboratories, Inc.
  • Orchid Chemicals and Pharmaceuticals, Ltd.
  • Par Pharmaceuticals, Inc.
  • Perrigo Company
  • PLIVA Pharmaceuticals, Inc.
  • Ranbaxy Laboratories, Ltd.
  • Roxane Laboratories, Inc.
  • Sandoz International, GmbH
  • Taro Pharmaceutical Industries Ltd.
  • TEVA Pharmaceutical Industries, Ltd.
  • Watson Pharmaceuticals, Inc.
  • United Research Laboratories and Mutual Pharmaceutical Company
  • Zydus Pharmaceuticals, Inc

Appendix: Company Directory

List of Exhibits

Chapter One: Executive Summary

• Table 1-1: Market Suumary: World Market for Prescription Generic Drugs Revenues by Segment 2000-2010
  • Figure 1-1: Market Summary: Trending in the World Market for Prescription Generic Drugs by Segment 2000-2010

Chapter Two: Introduction

• Figure 2-1: Abbreviated New Drug Application Review Flow Chart
  • Table 2-1: Brand Name Companies with Generic Subsidiaries
  • Table 2-2: Number of Best Selling Drugs with Patents Expiring in Years 2006-2012 Grouped by Treatment Category
  • Table 2-3: Best Selling Prescription Drugs with Expected Patent Expirations (Year of Expiration, Brand, Manufacturer, Indication, 2004 Revenues) 2006-2012

Chapter Three: Allergy and Respiratory Drugs

• Table 3-1: Prescription Allergy and Respiratory ANDA Approvals, 2005
  • Table 3-2: The World Market for Prescription Generic Allergy and Respiratory Drugs by Type 2000-2010
  • Figure 3-1: The World Market for Prescription Generic Allergy and Respiratory Drugs, Revenues by Type 2000-2010
  • Table 3-3: The World Market for Prescription Generic Allergy and Respiratory Drugs, Market Share by Type 2000-2010
  • Table 3-4: The World Market for Prescription Generic Allergy and Respiratory Drugs, U.S. Revenues and Share 2000-2010
  • Figure 3-2: The World Market for Prescription Generic Allergy and Respiratory Drugs, Displaying U.S. Revenues 2000-2010
  • Table 3-5: The World Market for Prescription Generic Allergy and Respiratory Drugs, Revenues and Market Share by Supplier 2005
  • Figure 3-3: The World Market for Prescription Generic Allergy and Respiratory Drugs, Market Share by Leading Supplier 2005

Chapter Four: Analgesics, Nonsteroidal Anti-Inflammatory Drugs, and Antirheumatic Drugs

• Table 4-1: Prescription Generic Analgesic, NSAID, and Antirheumatic ANDA Approvals, 2005
  • Table 4-2: The World Market for Prescription Generic Analgesics, NSAIDs and Antirheumatic Drugs by Type 2000-2010
  • Figure 4-1: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs, Revenues by Type 2000-2010
  • Table 4-3: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs, Market Share by Type 2000-2010
  • Table 4-4: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs, U.S. Revenues and Share 2000-2010
  • Figure 4-2: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs Displaying U.S. Revenues 2000-2010
  • Table 4-5: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs Revenues and Market Share by Supplier 2005
  • Figure 4-3: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs Market Share by Leading Supplier 2005

Chapter Five: Anesthesia Drugs

• Table 5-1: Prescription Generic Anesthesia Drug ANDA Approvals, 2005
  • Table 5-2: The World Market for Prescription Generic Anesthesia Drugs 2000-2010
  • Figure 5-1: The World Market for Prescription Generic Anesthesia Drugs Revenues 2000-2010
  • Table 5-3: The World Market for Prescription Generic Anesthesia Drugs, U.S. Revenues and Share 2000-2010
  • Figure 5-2: The World Market for Prescription Generic Anesthesia Drugs Displaying U.S. Revenues 2000-2010
  • Table 5-4: The World Market for Prescription Generic Anesthesia Drugs, Revenues and Market Share by Supplier 2005
  • Figure 5-3: The World Market for Prescription Generic Anesthesia Drugs Market Share by Leading Supplier 2005

CHAPTER Six: Anti-Infectives

• Table 6-1: Prescription Generic Anti-infective Drug ANDA Approvals, 2005
  • Table 6-2: The World Market for Prescription Generic Anti-Infective Drugs by Type 2000-2010
  • Figure 6-1: The World Market for Prescription Generic Anti-Infective Drugs, Revenues by Type 2000-2010
  • Table 6-3: The World Market for Prescription Generic Anti-Infective Drugs, Market Share by Type 2000-2010
  • Table 6-4: The World Market for Prescription Generic Anti-Infective Drugs U.S. Revenues and Share 2000-2010
  • Figure 6-2: The World Market for Prescription Generic Anti-Infective Drugs Displaying U.S. Revenues 2000-2010
  • Table 6-5: The World Market for Prescription Generic Anti-Infective Drugs, Revenues and Market Share by Supplier 2005
  • Figure 6-3: The World Market for Prescription Generic Anti-Infective Drugs Market Share by Leading Supplier 2005

Chapter Seven: Cancer Drugs

• Table 7-1: Prescription Generic Cancer Drug ANDA Approvals 2005
  • Table 7-2: The World Market for Prescription Generic Cancer Drugs 2000-2010
  • Figure 7-1: The World Market for Prescription Generic Cancer Drugs Revenues 2000-2010
  • Table 7-3: The World Market for Prescription Generic Cancer Drugs, U.S. Revenues and Share 2000-2010
  • Figure 7-2: The World Market for Prescription Generic Cancer Drugs Displaying U.S. Revenues 2000-2010
  • Table 7-4: The World Market for Prescription Generic Cancer Drugs, Revenues and Market Share by Supplier 2005
  • Figure 7-3: The World Market for Prescription Generic Cancer Drugs Market Share by Leading Supplier 2005

Chapter Eight: Cardiovascular Drugs

• Table 8-1: Prescription Generic Cardiovascular Drug ANDA
• Approvals. 2005
  • Table 8-2: The World Market for Prescription Generic Cardiovascular Drugs by Type 2000-2010
  • Figure 8-1: The World Market for Prescription Generic Cardiovascular Drugs Revenues by Type 2000-2010
  • Table 8-3: The World Market for Prescription Generic Cardiovascular Drugs, Market Share by Type 2000-2010
  • Figure 8-2: The World Market for Prescription Generic Cardiovascular Drugs, Share by Type 2005 and 2010
  • Table 8-4: The World Market for Prescription Generic Cardiovascular Drugs U.S. Revenues and Share 2000-2010
  • Figure 8-3: The World Market for Prescription Generic Cardiovascular Drugs Displaying U.S. Revenues 2000-2010
  • Table 8-5: The World Market for Prescription Generic Cardiovascular Drugs, Revenues and Market Share by Supplier 2005
  • Figure 8-4: The World Market for Prescription Generic Cardiovascular Drugs, Market Share by Leading Supplier 2001

Chapter Nine: Central Nervous System and Psychotherapeutic Drugs

• Table 9-1: Prescription Generic Central Nervous System/Psychotherapeutic Drug ANDA Approvals 2005
  • Table 9-2: The World Market for Prescription Generic Central Nervous System Drugs by Type 2000-2010
  • Figure 9-1: The World Market for Prescription Generic Central Nervous System Drugs Revenues by Type 2000-2010
  • Table 9-3: The World Market for Prescription Generic Central Nervous System Drugs, Market Share by Type 2000-2010
  • Table 9-4: The World Market for Prescription Generic Central Nervous System Drugs, U.S. Revenues and Share 2000-2010
  • Figure 9-2: The World Market for Prescription Generic Central Nervous System Drugs Displaying U.S. Revenues 2000-2010
  • Table 9-5: The World Market for Prescription Generic Central Nervous System Drugs, Revenues and Market Share by Supplier 2005
  • Figure 9-3: The World Market for Prescription Generic Central Nervous System Drugs, Market Share by Leading Supplier 2005

Chapter Ten: Gastrointestinal Drugs

• Table 10-1: Prescription Generic Gastrointestinal Drug ANDA Approvals 2005
  • Table 10-2: The World Market for Prescription Generic Gastrointestinal Drugs by Type, 2000-2010
  • Figure 10-1: The World Market for Prescription Generic Gastrointestinal Drugs Revenues by Type 2000-2010
  • Table 10-3: The World Market for Prescription Generic Gastrointestinal Drugs, Market Share by Type 2000-2010
  • Figure 10-2: The World Market for Prescription Generic Gastrointestinal Drugs, Share by Type 2005 and 2010
  • Table 10-4: The World Market for Prescription Generic Gastrointestinal Drugs, U.S. Revenues and Share 2000-2010
  • Figure 10-3: The World Market for Prescription Generic Gastrointestinal Drugs, Displaying U.S. Revenues 2000-2010
  • Table 10-5: The World Market for Prescription Generic Gastrointestinal Drugs, Revenues and Market Share by Supplier2005
  • Figure 10-4: The World Market for Prescription Generic Gastrointestinal Drugs, Market Share by Leading Supplier 2005

Chapter Eleven: Hormonal Drugs

• Table 11-1: Prescription Generic Hormone Drug ANDA Approvals 2005
  • Table 11-2: The World Market for Prescription Generic Hormone Drugs by Type 2000-2010
  • Figure 11-1: The World Market for Prescription Generic Hormone Drugs Revenues by Type 2000-2010
  • Table 11-3: The World Market for Prescription Generic Hormone Drugs, Market Share by Type 2000-2010
  • Figure 11-2: The World Market for Prescription Generic Hormone Drugs Share by Type 2005 and 2010
  • Table 11-4: The World Market for Prescription Generic Hormone Drugs U.S. Revenues and Share 2000-2010
  • Figure 11-3: The World Market for Prescription Generic Hormone Drugs Displaying U.S. Revenues 2000-2010
  • Table 11-5: The World Market for Prescription Generic Hormone Drugs, Revenues and Market Share by Supplier 2005
  • Figure 11-4: The World Market for Prescription Generic Hormone Drugs Market Share by Leading Supplier 2005

Chapter Twelve: Ophthalmic Drugs

• Table 12-1: Prescription Generic Ophthalmic Drug ANDA Approvals 2001
  • Table 12-2: The World Market for Prescription Generic Ophthalmic Drugs by Type 2000-2010
  • Figure 12-1: The World Market for Prescription Generic Ophthalmic Drugs Revenues by Type 2000-2010
  • Table 12-3: The World Market for Prescription Generic Ophthalmic Drugs, Market Share by Type 2000-2010
  • Table 12-4: The World Market for Prescription Generic Ophthalmic Drugs, U.S. Revenues and Share 2000-2010
  • Figure 12-2: The World Market for Prescription Generic Ophthalmic Drugs Displaying U.S. Revenues 2000-2010
  • Table 12-5: The World Market for Prescription Generic Ophthalmic Drugs, Revenues and Market Share by Supplier 2005
  • Figure 12-3: The World Market for Prescription Generic Ophthalmic Drugs Market Share by Leading Supplier 2005

Chapter Thirteen: World Market Summary

• Table 13-1: The World Market for Prescription Generic Drugs Revenues by Segment 2000-2010
  • Figure 13-1: The World Market for Prescription Generic Drugs Revenues by Segment 2000-2010
  • Figure 13-2: The World Market for Generic Drugs Market Share by Type 2005 and 2010
  • Table 13-3: World Market for Prescription Generic Drugs Revenues and Segments of Participation by Leading Player 2005

Chapter Fourteen: Issues and Trends

• Table 14-1: Reorganization of Major Japanese Generic Drug Manufacturers